Despite strong revenue growth and promising future estimates...
Despite strong revenue growth and promising future estimates, the company's lower than expected P/S ratio suggests a lack of investor confidence in its growth potential. Weak share price and low P/S ratio may indicate perceived risks and potential revenue instability.
It's Down 26% But Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Could Be Riskier Than It Looks
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment